GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Atricure, Inc. (ATRC) [hlAlert]

Rating:
Buy ATRC
up 47.50 %

Atricure, Inc. (ATRC) rated Buy with price target $22 by Stifel

Posted on: Tuesday,  Feb 24, 2015  8:25 AM ET by Stifel

Stifel rated Buy Atricure, Inc. (NASDAQ: ATRC) on 02/24/2015, when the stock price was $17.81. Since
then, Atricure, Inc. has gained 47.50% as of 01/06/2016's recent price of $26.27.
If you would have followed this Stifel's recommendation on ATRC, you would have gained 47.5% of your investment in 316 days.

AtriCure, Inc. is a medical device company that develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. The Company's primary product line, which accounts for a majority of its revenues, is the AtriCure Isolator system. AtriCure's Isolator system consists primarily of a compact power generator known as an ablation and sensing unit (ASU), a switchbox unit (ASB), which allows physicians to toggle between multiple products and multiple configurations of its Isolator clamps, including its Isolator Synergy clamps. AtriCure also sells a multifunctional bipolar pen, or multifunctional pen, which is often used by physicians in combination with its Isolator system to ablate cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias. In 2008, The Company received FDA approval for its EXCLUDE clinical trial.

Stifel
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2015 8:25 AM Buy
None
17.81 22.00
as of 8/27/2015
1 Week down  -2.52 %
1 Month up  7.66 %
3 Months up  20.00 %
1 YTD up  47.50 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy